Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/03/2012EP2505592A1 Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity
10/03/2012EP2505207A2 Modified exendins and uses thereof
10/03/2012EP2505206A2 Immunomodulating polypeptides derived from il-2 and use thereof in the therapeutic of cancer and chronic infections
10/03/2012EP2505205A1 Anti-PDGFR Alpha Antibodies
10/03/2012EP2505204A2 Method of treating prostate cancer with the GnRH antagonist degarelix
10/03/2012EP2505200A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of scleroderma
10/03/2012EP2505189A1 Stabilizing alkylglycoside compositions and method thereof
10/03/2012EP2504428A2 Methods and compositions for treating oxalate-related conditions
10/03/2012EP2504357A2 Recombinant filaggrin polypeptides for cell importation
10/03/2012EP2504354A2 Viral citrullinated peptides and uses thereof
10/03/2012EP2504353A2 Lipopeptide compositions and related methods
10/03/2012EP2504351A1 Melanocortin-1 receptor-specific linear peptides
10/03/2012EP2504349A1 Method of purifying pegylated proteins
10/03/2012EP2504035A2 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
10/03/2012EP2504032A2 Antagonists of il-6 to prevent or treat thrombosis
10/03/2012EP2504031A2 Antibodies to il-6 and use thereof
10/03/2012EP2504030A2 Antagonists of il-6 to raise albumin and/or lower crp
10/03/2012EP2504027A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
10/03/2012EP2504026A1 Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
10/03/2012EP2504025A2 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
10/03/2012EP2504024A2 Method for the therapy and diagnosis of alzheimer's disease
10/03/2012EP2504023A2 Novel peptides isolated from spider venom, and uses thereof
10/03/2012EP2504022A1 Brain tumor targeting peptides and methods
10/03/2012EP2504021A1 Polypeptide conjugate
10/03/2012EP2504020A1 Formulations of daptomycin
10/03/2012EP2504019A2 Mucosal delivery composition comprising a peptide complexed with a crown compound and/or a counter ion
10/03/2012EP2504015A2 Socs3 inhibition promotes cns neuron regeneration
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN1950100B Multi-component biological transport systems
10/03/2012CN1894281B Treatment of viral infections
10/03/2012CN1856321B Use of calcitonin in osteoarthritis
10/03/2012CN1846000B HPV CD8+ T-cell epitopes
10/03/2012CN1759176B Diagnosis and treatment of multiple sulfatase deficiency andother sulfatase deficiencies using a formylglycine generating enzyme (FGE)
10/03/2012CN1729013B Broad spectrum anti-viral therapeutics and prophylaxis
10/03/2012CN1658898B Orodispersible pharmaceutical composition comprising perindopril
10/03/2012CN1638787B Helicobacter pylori adhesion inhibitor
10/03/2012CN102712697A Vault complexes for cytokine delivery
10/03/2012CN102712689A Avian colony stimulating factor 1 receptor binding proteins
10/03/2012CN102712685A WNT 10-derived peptide and use thereof
10/03/2012CN102712677A Lipopeptide compositions and related methods
10/03/2012CN102712676A Template-fixed peptidomimetics with CCR10 antagonistic activty
10/03/2012CN102712675A Peptidomimetic macrocycles
10/03/2012CN102712644A Novel macrocyclic inhibitors of hepatitis C virus replication
10/03/2012CN102711832A Composition for controlling weight gain and food product containing same
10/03/2012CN102711824A Vaccines directed to Langerhans cells
10/03/2012CN102711815A Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
10/03/2012CN102711808A Enzymatic wound debriding compositions with enhanced enzymatic activity
10/03/2012CN102711807A Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract
10/03/2012CN102711806A Suppression of cancer metastasis
10/03/2012CN102711805A Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
10/03/2012CN102711804A Pharmaceutical composition comprising a GLP-1 agonist and methionine
10/03/2012CN102711803A GLP-2 for use in intestine and muscle recovery
10/03/2012CN102711802A Peptidic GLP-2 agonists
10/03/2012CN102711801A Method for treating heart failure with stresscopin-like peptides
10/03/2012CN102711800A Composition and method for treatment of diabetes
10/03/2012CN102711799A Compositions and methods for wound treatment
10/03/2012CN102711798A Pharmaceutical compositions for the stimulation of stem cells
10/03/2012CN102711797A Compositions and methods for treatment of aortic fibrosis
10/03/2012CN102711796A Application and uses of PRG4 and therapeutic modulation thereof
10/03/2012CN102711795A BChE albumin fusions for the treatment of cocaine abuse
10/03/2012CN102711794A Dps fusion proteins for use in vaccines and diagnostics
10/03/2012CN102711793A Chaperonin 10 variants
10/03/2012CN102711792A Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
10/03/2012CN102711791A HIV related peptides combination or fusion for use in HIV vaccine composition or as diagnostic means
10/03/2012CN102711790A Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
10/03/2012CN102711789A Therapeutic agents for reducing parathyroid hormone levels
10/03/2012CN102711788A Targeted delivery using tissue-specific peptidomimetic ligands
10/03/2012CN102711787A PAR1 antagonists for use in the treatment or prevention of influenza virus type A infections
10/03/2012CN102711786A Sebum secretion-blocking composition, and food or beverage containing same
10/03/2012CN102711785A Methods for the prevention or treatment of heart failure
10/03/2012CN102711777A Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
10/03/2012CN102711733A Growth hormone composition which is instantly connected with polymer carrier
10/03/2012CN102711731A Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition
10/03/2012CN102711728A Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
10/03/2012CN102703491A Bacteria-cracking preparation for effectively cracking escherichia coli as well as cracking method and application thereof
10/03/2012CN102703489A Construction method for prokaryotic secretory expression vector of protein transduction domain-Apoptin (PTD-Apoptin) fusion protein and application of prokaryotic secretory expression vector
10/03/2012CN102703472A Pathogenesis-related protein gene of hulless oat and protein encoded by pathogenesis-related protein gene
10/03/2012CN102703458A Solen grandis serpin Sgkunitz gene as well as recombinant protein and application thereof
10/03/2012CN102703457A Method for preparing and expressing antibacterial peptide gene
10/03/2012CN102702333A Drug-resistant pathogen infection resistant polypeptide and uses thereof
10/03/2012CN102702330A Intermedin analogue prepared by bonding ring core sequence with biotin or cell-penetrating peptides
10/03/2012CN102702319A HLA-A*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
10/03/2012CN102702318A YIGSKYIGSK with target antithrombotic activity, and preparation and application thereof
10/03/2012CN102702317A RGDSYIGSR with target antithrombotic activity, preparation and application thereof
10/03/2012CN102702316A RGDFYIGSK with targeting antithrombotic activity, preparation and applications thereof
10/03/2012CN102702315A RGDSYIGSK with targeting antithrombotic activity, preparation and applications thereof
10/03/2012CN102702314A RGDF-YIGSR with targeted anti-thrombotic activity, preparation and application thereof
10/03/2012CN102702313A RGDV-YIGSR with targeted anti-thrombotic activity, preparation and application thereof
10/03/2012CN102702312A RGDVYIGSK with targeting antithrombotic activity, preparation and applications thereof
10/03/2012CN102702310A Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines
10/03/2012CN102698287A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
10/03/2012CN102698270A Method for enhancing therapeutic agent uptake by target cell and pharmaceutical composition
10/03/2012CN102698265A Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
10/03/2012CN102698257A Anti-cancer drug composition and preparation method thereof
10/03/2012CN102698256A Medicine composition for treating tumor and preparation method for medicine composition
10/03/2012CN102698255A Anti-tumor medicine composition and application, kit and package
10/03/2012CN102698254A Composition for increasing bone mineral density, preparation agent containing same, and preparation method of same
10/03/2012CN102698253A Adenosine disodium triphosphate composition
10/03/2012CN102698252A Medicine composition for treating tumor and preparation method for medicine composition
10/03/2012CN102698251A Injection for expelling toxin and whitening skin
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 3163